Published in QJM on February 27, 2006
A prospective observational study of the relationship of critical illness associated hyperglycaemia in medical ICU patients and subsequent development of type 2 diabetes. Crit Care (2010) 1.33
Prognostic significance of hemoglobin A1c level in patients hospitalized with coronary artery disease. A systematic review and meta-analysis. Cardiovasc Diabetol (2011) 1.05
Hyperglycaemia and mortality. J R Soc Med (2007) 0.99
No association between hemoglobin A1c and in-hospital mortality in patients with diabetes and acute myocardial infarction. Am Heart J (2011) 0.95
The prognostic significance of serum glucose levels after the onset of ventricular arrhythmia on in-hospital mortality of patients with acute coronary syndrome. Rev Diabet Stud (2008) 0.77
Admission glucose, fasting glucose, HbA1c levels and the SYNTAX score in non-diabetic patients undergoing coronary angiography. Clin Res Cardiol (2013) 0.77
Hemoglobin A1c is a better predictor of prognosis following the non-ST elevation acute coronary syndrome than fasting and admission glucose. Wien Klin Wochenschr (2013) 0.76
The threshold of admission glycemia as a predictor of adverse events in diabetic and non-diabetic patients with acute coronary syndrome. Clin Med Cardiol (2009) 0.75
Single measurements of glycaemic markers may lack stability over time. QJM (2006) 0.75
Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med (1999) 3.81
Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation (1998) 3.70
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA (1997) 3.51
Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J (2002) 2.98
[Measuring the blood pressure in both arms is of little use; longitudinal study into blood pressure differences between both arms and its reproducibility in patients with diabetes mellitus type 2]. Ned Tijdschr Geneeskd (2007) 2.82
Death on the waiting list for cardiac surgery in The Netherlands in 1994 and 1995. Heart (1999) 2.40
Candidate reference methods for hemoglobin A1c based on peptide mapping. Clin Chem (1997) 2.35
Closure of the femoral artery after cardiac catheterization: a comparison of Angio-Seal, StarClose, and manual compression. Catheter Cardiovasc Interv (2008) 2.12
[Microalbuminuria in patients with type 2 diabetes mellitus in general practice]. Ned Tijdschr Geneeskd (2004) 2.07
[Acute myocardial infarct? Open the blood vessel involved]. Ned Tijdschr Geneeskd (1993) 2.06
Angioplasty vs thrombolysis for acute myocardial infarction: a quantitative overview of the effects of interhospital transportation. Eur Heart J (2003) 1.97
Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation (1998) 1.87
Influence of treatment delay on infarct size and clinical outcome in patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol (1998) 1.77
Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group. Lancet (1997) 1.77
Long-term recovery of left ventricular function after primary angioplasty for acute myocardial infarction. Eur Heart J (2001) 1.71
Out-of-hospital ventricular fibrillation in patients with acute myocardial infarction: coronary angiographic determinants. J Am Coll Cardiol (2000) 1.61
A randomized comparison of intra-aortic balloon pumping after primary coronary angioplasty in high risk patients with acute myocardial infarction. Eur Heart J (1999) 1.61
Angiographic findings and catheterization laboratory events in patients with primary coronary angioplasty or streptokinase therapy for acute myocardial infarction. Eur Heart J (1995) 1.60
Evaluation of the Menarini-Arkray HA 8140 hemoglobin A1c analyzer. Clin Chem (1997) 1.53
Intraperitoneal insulin infusion: treatment option for type 1 diabetes resulting in beneficial endocrine effects beyond glycaemia. Clin Endocrinol (Oxf) (2014) 1.52
Shared care with task delegation to nurses for type 2 diabetes: prospective observational study. Neth J Med (2005) 1.50
Bleeding attributed to the intake of paroxetine. Am J Psychiatry (1994) 1.49
Role of collateral circulation in the acute phase of ST-segment-elevation myocardial infarction treated with primary coronary intervention. Eur Heart J (2004) 1.48
Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: a prospective population-based study in The Netherlands (ZODIAC-1). Eur J Epidemiol (2003) 1.46
Incidence, predictors, and outcome of reinfarction and stent thrombosis within one year after primary percutaneous coronary intervention for ST-elevation myocardial infarction. Catheter Cardiovasc Interv (2009) 1.45
[Dobutamine therapy at home under the guidance of a nurse practitioner, either as a bridge to cardiac transplantation or as destination therapy in severe heart failure]. Ned Tijdschr Geneeskd (2007) 1.45
Limitation of myocardial infarct size after primary angioplasty: is a higher patency the only mechanism? Am Heart J (1999) 1.43
[Reports of suspected side effects of selective serotonin reuptake inhibitors in Belgium and The Netherlands]. Ned Tijdschr Geneeskd (1996) 1.42
High dose bolus heparin as initial therapy before primary angioplasty for acute myocardial infarction: results of the Heparin in Early Patency (HEAP) pilot study. J Am Coll Cardiol (1998) 1.42
Preparation of a candidate primary reference material for the international standardisation of HbA1c determinations. Clin Chem Lab Med (1998) 1.41
Sumatriptan and chest pain. Lancet (1993) 1.41
Assessment of coronary artery bypass graft patency by multidetector computed tomography and electron-beam tomography. Int J Cardiovasc Imaging (2005) 1.40
Long-term clinical outcome of patients with diabetes proposed for coronary revascularisation. Neth J Med (2006) 1.39
Ticlopidine and renal function. Lancet (1996) 1.39
A nested case-control study on mortality in users of ibopamine. Neth J Med (1997) 1.39
[Chest pain due to sumatriptan]. Ned Tijdschr Geneeskd (1992) 1.38
[A patient with heart failure and a new murmur: not always a valvular problem]. Ned Tijdschr Geneeskd (2005) 1.38
[Multidetector computed tomography of the coronary arteries]. Ned Tijdschr Geneeskd (2004) 1.38
Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction. Circulation (1994) 1.32
Glycosylated haemoglobin in renal failure. Diabetologia (1980) 1.30
Immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: left ventricular ejection fraction, hospital mortality and reinfarction. J Am Coll Cardiol (1994) 1.30
Conditions mimicking acute ST-segment elevation myocardial infarction in patients referred for primary percutaneous coronary intervention. Neth Heart J (2008) 1.29
Incidence of lead dislodgement, malfunction and perforation during the first year following device implantation. Neth Heart J (2014) 1.23
Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results. Neth Heart J (2008) 1.16
NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med (1998) 1.14
Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials. Am Heart J (2003) 1.12
Development of a reference system for the international standardization of HbA1c/glycohemoglobin determinations. J Int Fed Clin Chem (1996) 1.11
Determinations of proteins and hormones in serum by an immunoassay using antigen-enzyme conjugates. Clin Chim Acta (1972) 1.10
Calcium scoring using 64-slice MDCT, dual source CT and EBT: a comparative phantom study. Int J Cardiovasc Imaging (2007) 1.10
Predictive value of reactive hyperemic response on reperfusion on recovery of regional myocardial function after coronary angioplasty in acute myocardial infarction. Circulation (1994) 1.09
Effect of gender difference on platelet reactivity. Neth Heart J (2011) 1.09
The influence of cardiovascular disease on quality of life in type 2 diabetics. Qual Life Res (2002) 1.08
The localization of histone H3.3 in germ line chromatin of Drosophila males as established with a histone H3.3-specific antiserum. Chromosoma (1997) 1.08
Electrical storms in Brugada syndrome successfully treated with isoproterenol infusion and quinidine orally. Neth Heart J (2007) 1.08
Major achievements in cardiology in the past century: influence on Dutch cardiovascular medicine. Neth Heart J (2009) 1.07
Circumflex artery-related acute myocardial infarction: limited ECG abnormalities but poor outcome. Neth Heart J (2007) 1.07
Cross-sectional relationship between glycaemic control, hyperglycaemic symptoms and quality of life in type 2 diabetes (ZODIAC-2). Neth J Med (2005) 1.06
A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction. Am J Cardiol (1995) 1.05
Structure and expression of histone H3.3 genes in Drosophila melanogaster and Drosophila hydei. Genome (1995) 1.04
Primary percutaneous coronary intervention versus thrombolytic treatment: long term follow up according to infarct location. Heart (2005) 1.04
Quantification of global left ventricular function: comparison of multidetector computed tomography and magnetic resonance imaging. a meta-analysis and review of the current literature. Acta Radiol (2006) 1.04
Loss of taste and terbinafine. Lancet (1992) 1.02
Micropia: a retrotransposon of Drosophila combining structural features of DNA viruses, retroviruses and non-viral transposable elements. J Mol Biol (1988) 1.02
Acute and subacute stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: incidence, predictors and clinical outcome. J Thromb Haemost (2010) 1.01
Long-term impact of multivessel disease on cause-specific mortality after ST elevation myocardial infarction treated with reperfusion therapy. Heart (2006) 1.00
Adoption of prasugrel into routine practice: rationale and design of the Rijnmond Collective Cardiology Research (CCR) study in percutaneous coronary intervention for acute coronary syndromes. Neth Heart J (2014) 1.00
Atrial fibrillation after but not before primary angioplasty for ST-segment elevation myocardial infarction of prognostic importance. Neth Heart J (2012) 0.99
Preinfarction angina protects against out-of-hospital ventricular fibrillation in patients with acute occlusion of the left coronary artery. J Am Coll Cardiol (2001) 0.98
Treatment of non-culprit lesions detected during primary PCI: long-term follow-up of a randomised clinical trial. Neth Heart J (2012) 0.98
[Clinical presentations mimicking acute myocardial infarction; therapeutic pitfalls]. Ned Tijdschr Geneeskd (1998) 0.98
DNA sequence comparison of micropia transposable elements from Drosophila hydei and Drosophila melanogaster. Chromosoma (1990) 0.98
Is routine stenting for acute myocardial infarction superior to balloon angioplasty? A randomised comparison in a large cohort of unselected patients. Heart (2005) 0.98
Self-monitoring of blood glucose in tablet-treated type 2 diabetic patients (ZODIAC). Neth J Med (2010) 0.98
Development and validation of a patient-tailored dose regime in myocardial perfusion imaging using CZT-SPECT. J Nucl Cardiol (2014) 0.97
Quality of life of patients with type I diabetes mellitus. Qual Life Res (2003) 0.97
Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction. Am J Cardiol (2001) 0.97